Biotechbiotechnologycancerdrug developmentSTAT+ Archives - San Francisco Biotechnology Network | Bay Area Life Science News, Jobs & Events

News Ticker

[ January 27, 2023 ] Senior Research Associate, Discovery Biology – BridgeBio – Palo Alto, CA San Francisco Biotech Jobs
[ January 27, 2023 ] Postdoctoral Fellow – Microbial and Cell-Free Engineering – Lawrence Berkeley National Laboratory – San Francisco Bay Area, CA San Francisco Biotech Jobs
[ January 27, 2023 ] Better ways to build an airplane News
[ January 27, 2023 ] Gilead Sciences to Present at Upcoming Investor Conferences News
[ January 27, 2023 ] Director, Software Engineering (Remote) – Freenome Holdings – South San Francisco, CA San Francisco Biotech Jobs

STAT+: Studies of Gilead blood cancer drug interrupted by emerging safety issue, clouding its future

January 26, 2022 San Francisco Biotechnology Network News Comments Off

The development of a blood cancer drug acquired by Gilead Sciences — the centerpiece of a $5 billion deal — has been interrupted by a potentially serious safety issue. […]